Details for New Drug Application (NDA): 021463
✉ Email this page to a colleague
The generic ingredient in FORTESTA is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 021463
Tradename: | FORTESTA |
Applicant: | Endo Operations |
Ingredient: | testosterone |
Patents: | 0 |
Pharmacology for NDA: 021463
Mechanism of Action | Androgen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 021463
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL, METERED;TRANSDERMAL | Strength | 10MG/0.5GM ACTUATION | ||||
Approval Date: | Dec 29, 2010 | TE: | RLD: | Yes |
Expired US Patents for NDA 021463
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Operations | FORTESTA | testosterone | GEL, METERED;TRANSDERMAL | 021463-001 | Dec 29, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Endo Operations | FORTESTA | testosterone | GEL, METERED;TRANSDERMAL | 021463-001 | Dec 29, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription